EyeGate Pharma Receives USPTO Notice of Allowance for Next Generation of Proprietary Iontophoretic Delivery System
Patent to Provide Broad Coverage for EyeGate II® Delivery System with Pre-filled Drug Applicator Also,Patent Covering Proprietary Dexamethasone Phosphate Pharmaceutical Formulation Granted WALTHAM, Mass., Oct. 15, 2015 (GLOBE NEWSWIRE) -- Eyegate …